引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 826次   下载 632 本文二维码信息
码上扫一扫!
冬病夏治丸联合信必可治疗慢性阻塞性肺疾病稳定期30例临床观察
张 建,,李 红,,刘成高
0
(湖南省衡阳市中医医院,湖南 衡阳,421001)
摘要:
目的:观察冬病夏治丸联合信必可治疗慢性阻塞性肺疾病(COPD)稳定期的临床疗效。方法:将60例COPD稳定期患者随机分为2组各30例。对照组采用信必可吸入治疗,治疗组在对照组基础上加冬病夏治丸治疗,疗程均为3个月。观察2组患者治疗前后CAT评分、血气分析及肺功能情况。结果:2组CAT评分、血气指标、肺功能指标治疗后组间比较,差异均有统计学意义(P<0.01)。结论:冬病夏治丸联合信必可可明显改善COPD稳定期患者的临床症状、血气指标和肺功能,优于单纯应用信必可治疗。
关键词:  慢性阻塞性肺疾病  中医药疗法  冬病夏治丸  信必可
DOI:
Clinical effect of Dongbingxiazhi pills combined with Symbicort in treatment of stable chronic obstructive pulmonary disease:an analysis of 30 cases
ZHANG Jian,,LI Hong,,LIU Cheng-gao
(Hengyang Hospital of Traditional Chinese Medicine,Hengyang 421001,Hunan,China)
Abstract:
Objective:To investigate the clinical effect of Dongbingxiazhi pills combined with Symbicort in the treatment of stable chronic obstructive pulmonary disease(COPD).Methods:A total of 60 patients with stable COPD were randomly divided into treatment group and control group,with 30 patients in each group.The patients in the control group were given inhalation therapy with Symbicort,and those in the treatment group were given Dongbingxiazhi pills in addition to the treatment in the control group.The course of treatment was 3 months for both groups.The two groups were compared in terms of COPD Assessment Test(CAT)score,blood gas parameters,and pulmonary function before and after treatment.Results:After treatment,there were significant differences between the two groups in CAT score,blood gas parameters,and pulmonary function parameters(P<0.01).Conclusion:In patients with stable COPD,Dongbingxiazhi pills combined with Symbicort can significantly improve their clinical symptoms,blood gas parameters,and pulmonary function and have a better clinical effect than Symbicort alone.
Key words:  chronic obstructive pulmonary disease  traditional Chinese medicine treatment  Dongbingxiazhi pill  Symbicort

用微信扫一扫

用微信扫一扫